About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Plasma Betatrophin Levels in Non-alcoholic Fatty Liver Disease

NCT02176811·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Gulhane School of Medicine

Age

20–40

Sex

MALE

Healthy volunteers

Accepted

You may be eligible if

Patients with biopsy proven non-alcoholic fatty liver disease

You may not be if

Taking any drugs
\>20 gr/day alcohol consumption
chronic metabolic diseases
morbid obesity

The record

StatusCompleted

PhaseNo phase

Taking part80

StartedJun 2009

UpdatedJun 27, 2014

Conditions

Non-alcoholic Fatty Liver Disease

Where1

Gulhane School of Medicine Department of Endocrinology and Metabolism
Ankara, Turkey (Türkiye)

Clareo Health | Plasma Betatrophin Levels in Non-alcoholic Fatty Liver Disease